Sunrest Lifescience IPO: Healthcare and personal care product manufacturer Sunrest Lifescience launched an initial public offer (IPO) on Tuesday, November 7, estimated to be worth Rs 10.9 crore. The public offer of Sunrest Lifescience is a fixed price issue, opened for subscription for three trading days till November 9.The Sunrest Lifesciences SME IPO comprises fresh issuance of 12.9  lakh shares.

COMMERCIAL BREAK
SCROLL TO CONTINUE READING

Here are some of the key things to know about the Sunrest Lifescience SME IPO:

Important dates

The basis of the allotment of shares under the Sunrest Lifescience IPO is set to be finalised tentatively on November 15. Successful bidders will get shares credited into their demat accounts on November 17, whereas other participants will have refunds initiated on November 16.

Issue price

Under the fixed price offer, Sunrest Lifescience shares will be available at Rs 84 in multiples of 1,600, which translates to Rs 1,34,400 per lot.

Sunrest Lifescience IPO listing date

Sunrest Lifescience shares are set to be listed on stock exchange NSE’s SME platform tentatively on November 20.

Sunrest Lifescience IPO: Book-running lead managers

Mark Corporate Advisors is the book running lead manager, whereas Skyline Financial Services is the registrar for the issue.

Sunrest Lifescience IPO : Fund Utilisation

The company aims to utilise the proceeds from the issue towards the meeting its working capital requirements, general corporate purposes, and public issue expenses.

What does Sunrest Lifescience do?

Incorporated in 2017, Sunrest Lifescience offers a diverse range of healthcare and personal care products. It has a host of over-the-counter (OTC) brands in the healthcare and personal care segments.

For all other news related to business, politics, tech, sports and auto, visit Zeebiz.com